In Western Europe, Actavis Launches A High-Profile Challenge To Pfizer's Lipitor
This article was originally published in The Pink Sheet Daily
Executive Summary
The generic company ships a version of atorvastatin in Spain, although the formulation differs slightly from the best-selling cholesterol pill.
You may also be interested in...
Pfizer Settlement With Ranbaxy Delays Generic Lipitor Entry
Pfizer expects to hold off generic competition for Lipitor (atorvastatin) in the United States until November 2011 under a settlement agreement with Ranbaxy
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.